日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Measuring reading time: Comparing logged and self-reported data in relation to reading skills

阅读时间测量:比较记录数据和自我报告数据与阅读技能的关系

Brossette, Brice; Persia-Leibnitz, Laurie; Chalbos, Mee-Jin; Prugnières, Chloé; Ducrot, Stéphanie

Prevention of postoperative complications with negative pressure wound therapy after complex breast cancer surgery: a study protocol of a randomised controlled trial (TPN-SEIN)

负压伤口治疗预防复杂乳腺癌手术后并发症:一项随机对照试验的研究方案(TPN-SEIN)

Neron, Mathias; Delmond, Laure; Gourgou, Sophie; Delaine, Stéphanie; Chalbos, Patrick; Moussion, Aurore; Taoum, Christophe

Regorafenib plus FOLFIRINOX as first-line treatment for patients with RAS-mutant metastatic colorectal cancer (FOLFIRINOX-R trial): a dose-escalation study

瑞戈非尼联合FOLFIRINOX方案作为RAS突变转移性结直肠癌患者的一线治疗(FOLFIRINOX-R试验):一项剂量递增研究

Adenis, Antoine; Ghiringhelli, François; Gauthier, Ludovic; Mazard, Thibault; Evesque, Ludovic; Evrard, Alexandre; Chalbos, Patrick; Moussion, Aurore; Gourgou, Sophie; Ychou, Marc

Cardiac coherence and medical hypnosis: a feasibility study of a new combined approach for managing preoperative anxiety in patients with breast or gynaecological cancer

心脏相干性和医学催眠:一种用于管理乳腺癌或妇科癌症患者术前焦虑的新型联合疗法的可行性研究

Amraoui, Jibba; Leclerc, Gilles; Jarlier, Marta; Diaz, Jesus; Guler, Ridvan; Demoly, Clément; Verin, Catherine; Rey Dit Guzer, Sophie; Chalbos, Patrick; Moussion, Aurore; Taoum, Christophe; Neron, Mathias; Philibert, Laurent

FOLFIRINOX-R study design: a phase I/II trial of FOLFIRINOX plus regorafenib as first line therapy in patients with unresectable RAS-mutated metastatic colorectal cancer

FOLFIRINOX-R 研究设计:一项 I/II 期临床试验,评估 FOLFIRINOX 联合瑞戈非尼作为一线疗法治疗 RAS 突变型不可切除转移性结直肠癌患者的疗效。

Adenis, Antoine; Mazard, Thibault; Fraisse, Julien; Chalbos, Patrick; Pastor, Brice; Evesque, Ludovic; Ghiringhelli, Francois; Mollevi, Caroline; Delaine, Stéphanie; Ychou, Marc

Therapeutic Activity of Anti-AXL Antibody against Triple-Negative Breast Cancer Patient-Derived Xenografts and Metastasis

抗AXL抗体对三阴性乳腺癌患者来源的异种移植瘤和转移的治疗活性

Wilhem Leconet, Myriam Chentouf, Stanislas du Manoir, Clément Chevalier, Audrey Sirvent, Imade Aït-Arsa, Muriel Busson, Marta Jarlier, Nina Radosevic-Robin, Charles Theillet, Dany Chalbos, Jean-Max Pasquet, André Pèlegrin, Christel Larbouret, Bruno Robert

Epithelial-to-mesenchymal transition induced by TGF-β1 is mediated by Blimp-1-dependent repression of BMP-5.

TGF-β1 诱导的上皮间质转化是由 Blimp-1 依赖性 BMP-5 抑制介导的

Romagnoli Mathilde, Belguise Karine, Yu Ziyang, Wang Xiaobo, Landesman-Bollag Esther, Seldin David C, Chalbos Dany, Barillé-Nion Sophie, Jézéquel Pascal, Seldin Margaret L, Sonenshein Gail E

The PKCθ pathway participates in the aberrant accumulation of Fra-1 protein in invasive ER-negative breast cancer cells

PKCθ通路参与了侵袭性ER阴性乳腺癌细胞中Fra-1蛋白的异常积累。

Belguise, K; Milord, S; Galtier, F; Moquet-Torcy, G; Piechaczyk, M; Chalbos, D

PTPN13/PTPL1: an important regulator of tumor aggressiveness

PTPN13/PTPL1:肿瘤侵袭性的重要调节因子

Freiss, Gilles; Chalbos, Dany

The role of sex steroid receptors on lipogenesis in breast and prostate carcinogenesis: a viewpoint

性激素受体在乳腺癌和前列腺癌发生过程中脂肪生成中的作用:一种观点

Rochefort, Henri; Chalbos, Dany